06/18/2026
Recent headlines about ACOG's new maternal vaccine schedule have made it sound as though there is widespread disagreement about vaccines during pregnancy.
The reality is more nuanced.
ACOG's decision to withdraw from the federal vaccine advisory process is significant and reflects concerns the organization has raised about scientific integrity and the vaccine review process.
But for patients, one of the most important takeaways is that many recommendations remain unchanged, including guidance on Flu, Tdap, and RSV vaccination during pregnancy.
When reporting on healthcare guidance, clarity matters.
Pregnant patients are already navigating an overwhelming amount of information. Headlines that oversimplify disagreements can create confusion and make it harder for patients to understand what recommendations actually apply to them.
These conversations are not abstract policy debates. They involve decisions that can affect the health of both mothers and babies.
I wrote a brief article breaking down what changed, what didn't, and what pregnant patients should know.
Recent headlines have suggested a major divide between ACOG and federal vaccine guidance. While there has been an important organizational shift, the reality is more nuanced.